在COVID-19疫苗接种和感染后发生血栓的风险:风险效益分析
Lili Zhao1, Huong Tran2, Malcolm Risk1
1University of Michigan.
Research square
|June 17, 2024
概括
接种COVID-19疫苗显示血液凝块风险略有增加. 然而,疫苗显著降低了血栓的总体风险,特别是在高感染期.
科学领域:
- 流行病学 流行病学
- 公共卫生 公共卫生
- 疫苗学 疫苗学 疫苗学
背景情况:
- 在接种COVID-19疫苗后,血块是一种潜在的担忧.
- 了解确切的风险和益处对于公共卫生政策至关重要.
研究的目的:
- 为了分析COVID-19疫苗的风险-益处概况,关于血液凝块.
- 量化疫苗接种,感染和血栓风险之间的关联.
主要方法:
- 采用因果模型和自我控制的案例系列方法来评估疫苗接种风险.
- 利用一个病例对照研究来比较感染者与非感染者的血栓风险,调整住院偏差.
主要成果:
- 接种疫苗后观察到血栓风险略有增加 (接种剂量1后IRR为1.13;接种剂量2后IRR为1.23).
- 接种疫苗显著减轻了与COVID-19感染相关的血栓风险 (接种疫苗的OR为1.46与未接种疫苗的OR为2.16).
结论:
- 尽管风险略有增加,但COVID-19疫苗接种最终降低了血液凝块的整体风险.
- 在病毒循环较高的时期,保护作用最为明显,这突显了疫苗接种的净益处.
相关概念视频
Vaccinations
44.4K
Overview
44.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Disorders of Hemostasis
831
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
831
Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K
Clot Retraction and Fibrinolysis
5.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.4K


